Showing 1 - 20 results of 38 for search 'Stem cell controversy', query time: 0.10s Refine Results
  1. 1
  2. 2
  3. 3

    Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation by Xiao-Hua Luo, Ying-Jun Chang, Xiao-Jun Huang

    Published 2014-01-01
    “…Stem cell source and donor age are other important factors. …”
    Get full text
    Article
  4. 4

    Gene Editing in Pluripotent Stem Cells and Their Derived Organoids by Hang Zhou, Yun Wang, Li-Ping Liu, Yu-Mei Li, Yun-Wen Zheng

    Published 2021-01-01
    “…With the rapid rise in gene-editing technology, pluripotent stem cells (PSCs) and their derived organoids have increasingly broader and practical applications in regenerative medicine. …”
    Get full text
    Article
  5. 5

    Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy by Quan Zhuang, Ruoyu Ma, Yanshuang Yin, Tianhao Lan, Meng Yu, Yingzi Ming

    Published 2019-01-01
    “…MSCs are pluripotent adult stem cells that can differentiate into various types of tissue lineages, such as the cartilage (chondrocytes), bone (osteoblasts), fat (adipocytes), and muscle (myocytes). …”
    Get full text
    Article
  6. 6

    Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option by Yantian Cao, Bangjie Zhang, Rong Lin, Qingzhi Wang, Jie Wang, Fangfang Shen

    Published 2018-01-01
    “…Background and Aims. Mesenchymal stem cell transplantation (MSCT) became available with liver failure (LF), while the advantages of MSCs remain controversial. …”
    Get full text
    Article
  7. 7

    Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat by Zurab Kakabadze, Nicholas Kipshidze, Teona Paresishvili, Nodar Kipshidze, Zurab Vadachkoria, David Chakhunashvili

    Published 2022-01-01
    “…Currently, there have been reports of efficient use of mesenchymal stem cells (MSCs) for the treatment of ARDS caused by COVID-19. …”
    Get full text
    Article
  8. 8

    Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia by Fabian Lang, Bartosch Wojcik, Michael A. Rieger

    Published 2015-01-01
    “…Cancer is characterized by a remarkable intertumoral, intratumoral, and cellular heterogeneity that might be explained by the cancer stem cell (CSC) and/or the clonal evolution models. …”
    Get full text
    Article
  9. 9

    The aging hematopoietic stem cell niche: a mini review by Xin Gao, Jing Zhang, Jing Zhang, Owen J. Tamplin

    Published 2025-02-01
    “…Hematopoietic stem cells (HSCs) undergo a functional decline during aging. …”
    Get full text
    Article
  10. 10

    Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application by Mengyuan Wang, Quan Yuan, Liang Xie

    Published 2018-01-01
    “…Mesenchymal stem cells (MSCs) are multipotent stem cells characterized by self-renewal, production of clonal cell populations, and multilineage differentiation. …”
    Get full text
    Article
  11. 11

    Eradication of HIV by Transplantation of CCR5-Deficient Hematopoietic Stem Cells by Gero Hütter, Susanne Ganepola

    Published 2011-01-01
    “…Our report raises the hope for further targeted treatment strategies against HIV and represents a successful personalized treatment with allogeneic stem cells carrying a beneficial gene. However, this case has ignited a controversy regarding the question of whether this patient has achieved complete eradication of HIV or not. …”
    Get full text
    Article
  12. 12

    Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells by Yeri Alice Rim, Yoojun Nam, Narae Park, Hyerin Jung, Yeonsue Jang, Jennifer Lee, Ji Hyeon Ju

    Published 2018-01-01
    “…Scientists have tried to reprogram various origins of primary cells into human induced pluripotent stem cells (hiPSCs). …”
    Get full text
    Article
  13. 13

    Therapeutic potential of mesenchymal stem cells for fungal infections: mechanisms, applications, and challenges by Yangjie Gao, Zhe Ji, Jingyu Zhao, Julin Gu

    Published 2025-01-01
    “…As a particularly serious condition in immunocompromised patients, fungal infections (FIs) have increasingly become a public health problem worldwide. Mesenchymal stem cells (MSCs), characterized by multilineage differentiation potential and immunomodulatory properties, are considered an emerging strategy for the treatment of FIs. …”
    Get full text
    Article
  14. 14

    Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells by Sophie Guelfi, Hugues Duffau, Luc Bauchet, Bernard Rothhut, Jean-Philippe Hugnot

    Published 2016-01-01
    “…Glioblastomas are devastating and extensively vascularized brain tumors from which glioblastoma stem-like cells (GSCs) have been isolated by many groups. …”
    Get full text
    Article
  15. 15

    Cartilage Defect Treatments: With or without Cells? Mesenchymal Stem Cells or Chondrocytes? Traditional or Matrix-Assisted? A Systematic Review and Meta-Analyses by Zhantao Deng, Jiewen Jin, Jianning Zhao, Haidong Xu

    Published 2016-01-01
    “…In the last two decades, promising new strategies by using assorted scaffolds and cell sources to induce tissue regeneration have emerged, such as autologous chondrocyte implantation (ACI) and mesenchymal stem cell implantation (MSCI). …”
    Get full text
    Article
  16. 16

    CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells by Lucas Touzet, Florent Dumezy, Christophe Roumier, Céline Berthon, Claire Bories, Bruno Quesnel, Claude Preudhomme, Thomas Boyer

    Published 2019-03-01
    “…Interestingly, CD9 expression was different between the more immature physiologic and AML cells (CD34+CD38−) as it was also expressed in AML on putative leukemic stem cells (LSCs) but not on hematopoietic stem cells (HSCs). …”
    Get full text
    Article
  17. 17

    Efficacy and Safety of Mesenchymal Stem Cells in Treatment of Complex Perianal Fistulas: A Meta-Analysis by Fang Cheng, Zhong Huang, Zhi Li

    Published 2020-01-01
    “…Complex perianal fistula is a highly debilitating and difficult to treat condition. Local mesenchymal stem cell (MSC) therapy for perianal fistula has shown considerable promise but still remains controversial. …”
    Get full text
    Article
  18. 18

    Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy by Pingting Ye, Lei Feng, Dan Zhang, Ruihao Li, Yixuan Wen, Xiaohan Tong, Shuo Shi, Chunyan Dong

    Published 2023-01-01
    “…Human bone marrow-derived mesenchymal stem cells (hBMSCs) are promising candidates for stem cell therapy in clinical trials. …”
    Get full text
    Article
  19. 19

    Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials by Baocheng Xie, Minyi Chen, Runkai Hu, Weichao Han, Shaobo Ding

    Published 2020-01-01
    “…In recent years, human mesenchymal stem cell (hMSC) transplantation has become a promising therapeutic strategy for CP. …”
    Get full text
    Article
  20. 20

    Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group by Anna Waszczuk-Gajda, David H. Vesole, Jolanta Małyszko, Artur Jurczyszyn, Tomasz Wróbel, Joanna Drozd-Sokołowska, Piotr Boguradzki, Krzysztof Mądry, Agnieszka Tomaszewska, Jarosław Biliński, Maria Król, Longin Niemczyk, Magdalena Olszewska-Szopa, Wieslaw W. Jedrzejczak, Grzegorz W. Basak

    Published 2020-04-01
    “…Introduction The prognostic factors in autotransplanted multiple myeloma (MM) patients with concomitant advanced chronic kidney disease (CKD) are poorly understood, limited, and controversial. Material and methods We retrospectively analysed 44 patients with MM and CKD (eGFR < 40 ml/min), present both at diagnosis and at autologous stem cell transplantation (ASCT), with no improvement of renal function in-between. …”
    Get full text
    Article